ey0015.3-2 | Thyroid development | ESPEYB15
S Liang , E Johansson , G Barila , DL Altschuler , H Fagman , M Nilsson
ey0015.9-2 | Late consequences of tumour therapy: prevention and monitoring | ESPEYB15
L Collins , L Beaumont , A Cranston , S Savoie , T Nayiager , R Barr
ey0015.9-13 | Biologic agents in chronic inflammatory diseases: lights and shadows | ESPEYB15
L Haas , R Chevalier , BT Major , F Enders , S Kumar , J Tung
ey0015.11-2 | New insight into obesity comorbidities | ESPEYB15
G Zabarsky , C Beek , E Hagman , B Pierpoint , S Caprio , R Weiss
ey0015.11-9 | The brain decides weight gain | ESPEYB15
S Carnell , L Benson , KY Chang , Z Wang , Y Huo , A Geliebter , BS Peterson
ey0015.11-18 | Prebiotics reduce fat mass | ESPEYB15
AC Nicolucci , MP Hume , I Martínez , S Mayengbam , J Walter , RA Reimer
ey0015.13-7 | How does paediatric endocrinology and diabetes fit in the global initiatives? | ESPEYB15
S Horton , R Sullivan , J Flanigan , KA Fleming , MA Kuti , LM Looi , SA Pai , M Lawler
ey0015.13-9 | Type 1 and Type 2 Diabetes in Resource-Limited Settings | ESPEYB15
N Lascar , J Brown , H Pattison , AH Barnett , CL Bailey , S Bellary
ey0015.13-12 | Type 1 and Type 2 Diabetes in Resource-Limited Settings | ESPEYB15
E Ameyaw , SB Asafo-Agyei , S Thavapalan , AC Middlehurst , GD Ogle
ey0015.13-18 | Advances in the Diagnosis and Management of Congenital Hypothyroidism | ESPEYB15
L Mehran , D Khalili , S Yarahmadi , A Amouzegar , M Mojarrad , N Ajang , F Azizi